[11C]raclopride and extrastriatal binding to D2/3 receptors

Bibliographic Details
Published in:	NeuroImage
Main Author:	Heiko Backes
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S1053811919309371

Similar Items

Dopamine D2/3-receptor availability and its association with autonomous motivation to exercise in older adults: An exploratory [11C]-raclopride study
by: Emma Simonsson, et al.
Published: (2022-11-01)

[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease
by: Adam J. Stark, et al.
Published: (2018-01-01)

In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT
by: Stergios Tsartsalis, et al.
Published: (2020-06-01)

A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
by: Nicole R. Zürcher, et al.
Published: (2021-01-01)

The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [<sup>11</sup>C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease
by: Heidy Jimenez, et al.
Published: (2023-07-01)

Levodopa effects on [11C]raclopride binding in the resting human brain [v1; ref status: indexed, http://f1000r.es/4oe]
by: Kevin J. Black, et al.
Published: (2015-01-01)

D2 receptor antagonist raclopride regulates glutamatergic neuronal activity in the pedunculopontine nucleus in a rat model of Parkinson's disease
by: Hongli Chang, et al.
Published: (2024-12-01)

Optimization of [C]Raclopride Positron Emission Tomographic Rat Studies: Comparison of Methods for Image Quantification
by: Èlia Torrent, et al.
Published: (2013-06-01)

Association between striatal subregions and extrastriatal regions in dopamine D(1) receptor expression: a positron emission tomography study.
by: Hironobu Fujiwara, et al.
Published: (2012-01-01)

Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice
by: Adam S. Ravalia, et al.
Published: (2021-05-01)

Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study
by: Robert Y. Moore, et al.
Published: (2008-03-01)

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
by: Nicolas Nicastro, et al.
Published: (2020-05-01)

Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
by: Merijn Joling, et al.
Published: (2018-01-01)

Separating dopamine D2 and D3 receptor sources of [11C]-(+)-PHNO binding potential: Independent component analysis of competitive binding
by: Kelly Smart, et al.
Published: (2020-07-01)

Corrigendum: Intra-accumbens raclopride administration prevents behavioral changes induced by intermittent access to sucrose solution
by: Josué O. Suárez-Ortiz, et al.
Published: (2023-03-01)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study
by: Merijn Joling, et al.
Published: (2019-01-01)

Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity
by: Nikolas Boy, et al.
Published: (2017-04-01)

[3H]-Spiperone Competition Binding to Dopamine D2, D3 and D4 Receptors
by: Jan-Peter Wieringen, et al.
Published: (2013-10-01)

[3H]-Spiperone Saturation Binding to Dopamine D2, D3 and D4 Receptors
by: Jan-Peter Wieringen, et al.
Published: (2013-10-01)

Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (11C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors
by: Lisheng Cai, et al.
Published: (2023-04-01)

P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study
by: Jussi Lehto, et al.
Published: (2024-12-01)

Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo
by: Giovanny Aguilera-Durán, et al.
Published: (2020-09-01)

The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.
by: Ravi Kumar Verma, et al.
Published: (2018-01-01)

Another surprise in receptor binding of C. difficile toxins
by: Klaus Aktories
Published: (2022-07-01)

Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys
by: Peter B. Rupert, et al.
Published: (2024-04-01)

Correlation Analysis Between 3D and Plane DAT Binding Parameters of 11C-CFT PET/CT and the Clinical Characteristics of Patients with Parkinson’s Disease
by: Xiaodong Wu, et al.
Published: (2025-04-01)

Function and Role of ATP-Binding Cassette Transporters as Receptors for 3D-Cry Toxins
by: Ryoichi Sato, et al.
Published: (2019-02-01)

Excitatory and inhibitory D-serine binding to the NMDA receptor
by: Remy A Yovanno, et al.
Published: (2022-10-01)

Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding
by: Robert Gustafsson, et al.
Published: (2018-04-01)

Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects
by: Zsolt Cselényi, et al.
Published: (2020-06-01)

Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease
by: Vincent N. Azzolino, et al.
Published: (2025-01-01)

[C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2
by: Olof Eriksson, et al.
Published: (2015-09-01)

The oncoprotein BCL11A binds to orphan nuclear receptor TLX and potentiates its transrepressive function.
by: Sara B Estruch, et al.
Published: (2012-01-01)

Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.
by: Piotr Ruchala, et al.
Published: (2010-04-01)

Crystal structure of 1-(benzo[d]thiazol-2-yl)-3-phenylthiourea, C14H11N3S2
by: Jambi Suhair M. S., et al.
Published: (2017-01-01)

Autoradiographic 3H-Gaboxadol Receptor Binding Protocol
by: Lynne Ling, et al.
Published: (2013-12-01)

DOES 11C-PK11195 BINDING PREDICT LESION GROWTH AT ONE YEAR?
by: Daniel Tozer, et al.
Published: (2024-01-01)

Receptor for activated C kinase 1 protein binds to and activates the human estrogen receptor α
by: Eric Adams, et al.
Published: (2014-01-01)

C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor
by: Manu Sudhakar, et al.
Published: (2018-05-01)

A small molecule enhances arrestin-3 binding to the β2-adrenergic receptor
by: Han Kurt, et al.
Published: (2025-07-01)